Palonosetron or granisetron for prevention of CINV in patients with breast cancer receiving dexamethasone and fosaprepitant following anthracycline plus cyclophosphamide (AC) regimen

Autor:	Kaisuke Miyamoto, Chiyo K. Imamura, Akitaka Makiyama, Kazuhiko Sato, Kenji Tamura, Mitsuchika Hosoda, Yasutaka Chiba, Shinichiro Nakamura, Mihoko Doi, Shinya Tokunaga, Kazuhiro Yanagihara, Masato Takahashi, Yasuaki Ryushima, Toshimi Takano, Kenjiro Aogi, Koji Matsumoto, Kimiko Fujiwara, Toshiaki Saeki, Yasuo Hozumi
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty Cyclophosphamide Anthracycline business.industry Palonosetron Granisetron medicine.disease AC Regimen humanities Fosaprepitant Breast cancer Anesthesia Internal medicine medicine business Dexamethasone medicine.drug
Zdroj:	Journal of Clinical Oncology. 33:9598-9598
ISSN:	1527-7755 0732-183X
Popis:	9598 Background: Superiority of palonosetron to granisetron is uncertain, for patients with breast cancer receiving both steroid and NK1 inhibitor against CINV caused by AC regimen. Methods: We con...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5b8bac2a599d622ca96ef2e171731246 https://doi.org/10.1200/jco.2015.33.15_suppl.9598 Zobrazit plný text záznamu